By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.

Vladimir Potanin, the owner and founder of Interros Group, one of the largest private investment companies in Russia, has completed acquisition of a controlling stake in Petrovax Pharm. For more details please visit www.petrovax.com

Vladimir Potanin and Mikhail Prokhorov finished a series of deals terminating their mutual trust and released each other from mutual claims. Entities close to M. Prokhorov purchased all OPIN shares owned by V.Potanins entities.

Vladimir Potanin and Mikhail Prokhorov reached an agreement on termination of a mutual trust. The trust agreement was inked by both parties on March 20, 2008 with the trust manager Andrey Klishas in order to manage mutual assets. Today, the parties signed a number of agreements which are to settle all issues related to the trusts assets as well as to free each party from mutual claims. The signed agreements also provide that business entities closed to M. Prokhorov are to purchase all OPIN shares owned by V.Potanins entities.